Preparation, characterization, and in vivo study of rhein solid lipid nanoparticles for oral delivery

of rhein in the form of SLNs was significantly increased and was 2.06-fold that of suspensions group. The results showed an increased oral absorption and improved the oral bioavailability of rhein by the formulation of SLNs.